The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration ...

Some patients with highly drug-resistant tuberculosis could benefit from a shorter treatment with fewer drugs, while others ...

The National Pharmaceutical Pricing Authority (NPPA) has revised the prices of 71 essential drug formulations, encompassing ...

Research shows promising results for a weekly injectable Parkinson's treatment that maintains consistent medication levels, ...

A large Danish study found that common infections during pregnancy, such as pneumonia and urinary tract infections, do not ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global Accelerator for Paediatric formulations (GAP-f), the World Health Organization ...

Patients with AD treated with dupilumab have a lower risk of various infections than those treated with methotrexate or cyclosporine.

A new medical study out of Johns Hopkins Children's Center could potentially be a game changer for those suffering certain ...